期刊文献+

ICU患者下呼吸道感染病原菌分布及耐药性分析 被引量:8

Analysis of distribution and drug resistance of pathogenic bacteria in patients with lower respiratory tract in-fection in ICU
原文传递
导出
摘要 目的:了解ICU患者下呼吸道感染病原菌的分布及其耐药性,为临床合理用药提供科学参考依据。方法采用VITEK-32全自动细菌鉴定仪进行菌种鉴定,用K-B药敏纸片扩散法测定细菌敏感性,使用WHONET 5.4软件进行统计学分析。结果 ICU患者下呼吸道感染病原菌中,共检出453株病原菌,革兰阴性菌332株占73.3%,前三位依次为铜绿假单胞菌115株占25.4%,肺炎克雷伯菌90株占19.8%,鲍氏不动杆菌38株占8.4%;革兰阳性菌102株占22.5%,前三位依次为金黄色葡萄球菌31株占6.8%,凝固酶阴性葡萄球菌22株占4.9%,肠球菌属18株,占4.0%。美罗培南、亚胺培南(嗜麦芽寡养单胞菌除外)和头孢哌酮/舒巴坦、阿米卡星对革兰阴性菌最敏感,替考拉宁和万古霉素对革兰阳性菌高度敏感。结论 ICU患者下呼吸道感染病原菌以革兰阴性杆菌为主,对常用抗菌药物耐药严重,加强对ICU的感染管理及危险因素控制,合理使用抗菌药物,降低病原菌的耐药率具有重要意义。 Objective To investigate the distribution and drug resistance of pathogenic bacteria in hospital ICU patients with lower respiratory tract infection , and provide scientific reference for clinical rational drug use . Methods The strains were identified by VITEK -32 automatic bacterial identification instrument , the bacterial sensitivity was determined by K -B disk diffusion method , and the statistical analysis was performed by WHONET 5.4 software.Results The total isolated pathogenic bacteria of lower respiratory tract infection in ICU patients was 453 strains.332 strains of gram negative bacteria accounted for 73.3%,and the former three ones were Pseudomonas aeruginosa (115 strains,accounted for 25.4%),Klebsiella pneumonia (90 strains,accounted for 19.8%),Acineto-bacter baumannii (38 strains,accounted for 8.4%).102 strains of gram positive bacteria accounted for 22.5%,and the top three were Staphylococcus aureus (31 strains,accounted for 6.8%),coagulase negative Staphylococcus (22 strains,accounted for 4.9%),Enterococcus (18 strains,accounted for 4%).Meropenem,imipenem (Stenotroph-omonas maltophilia was excepted ) ,Cefoperazone /sulbactam and Amikacin were most sensitive against gram negative bacteria;Teicoplanin and vancomycin were highly sensitive against gram positive bacteria .Conclusion The main pathogenic bacteria of respiratory tract infection in ICU patients was gram negative bacilli ,which were seriously resist-ant to commonly used antimicrobial drugs .So strengthening the infection management of ICU and the control for risk factors,and rationally using of antimicrobial drugs has great significance in reducing the drug resistance of pathogenic bacteria rate .
出处 《中国基层医药》 CAS 2015年第6期834-837,共4页 Chinese Journal of Primary Medicine and Pharmacy
基金 山东省优秀中青年科学家科研奖励基金项目(BS2010YY045) 山东省临床重点专科建设项目经费资助(鲁卫医字2013-26)
关键词 重症监护病房 下呼吸道感染 病原菌 耐药性 ICU lower respiratory tract infection pathogenic bacteria drug resistance
  • 相关文献

参考文献15

二级参考文献113

  • 1骆雪萍,孔晋亮,陈一强.呼吸机相关肺炎病原菌流行特征及病原菌产ESBLs的相关因素分析[J].广西医科大学学报,2006,23(3):433-435. 被引量:8
  • 2Diamandis EP, Yousef GM, Soosaipillai AR, et al. Human kallikrein 6 ( zyme/protease M/neurosin) : a new serum biomarker of ovarian carcinoma[ J ]. Clin Biochem ,2000,33 ( 7 ) :579 - 583.
  • 3Diamandis EP' Scorilas A, Fracehioli S, et al. Human kallikrein 6 (hK6):a new potential serum biomarker for diagnosis and prognosis of ovarian carcinoma [ J ]. J Clin Oncol, 2003,21 ( 6 ) : 1035 - 1043.
  • 4Rosen DG, Wang L, Atkinson JN, et al. Potential markers that complement expression of CA125 in epithelial ovarian cancer[ J]. Gynecol Oncol, 2005,99 (2) :267 - 277.
  • 5Dom J,Schmitt M,Kates R,et al. Primary tumor levels of human tissue kallikreins affect surgical success and survival in ovarian cancer patients [ J ]. Clin Cancer Res,2007,13 ( 6 ) : 1742 - 1748.
  • 6Meyer T, Rustin GJ. Role of tumor markers in monitoring epithelial ovarian cancer [ J ]. Br J Cancer,2000,82 ( 9 ) : 1535 - 1538.
  • 7Moss EL, Hollingworth J, Reynolds TM. The role of CA125 in ehnical practice [ J ]. J Clin Pathol,2005,58 ( 3 ) : 308 - 312.
  • 8Sica GL, Choi IH, Zhu G, et al. B7-H4, a molecule of the B7 family, negatively regulates T cell immunity [ J ]. Immunity,2003, 18(6) :849 -861.
  • 9Choi IH, Zhu G, Sica GL, et al. Genomic organization and expression analysis of B7-H4, an immune inhibitory molecule of the B7 family [ J ]. J Immunol,2003,171 ( 9 ) :4650 - 4654.
  • 10Sun Y, Wang Y, Zhao J, et al. B7-H3 and B7-H4 expression in non small eell lung cancer[ J]. Lung Cancer,2006,53 (2) :143 - 151.

共引文献809

同被引文献62

  • 1孙静意.老年住院患者医院感染研究进展及护理对策[J].医学信息,2015,2(9):71-71.
  • 2Ahmed NH,Hussain T,Biswal I.Antimicrobial resistance of bacterial isolates from respiratory secretions of ventilated patients in a multi-specialtyhospital[J].Avicenna J Med,2015,5(3):74-78.
  • 3Terraneo S,Ferrer M,Martín-Loeches I,et al.Impact of Candida spp.isolation in the respiratory tract in patients with intensive care unit-acquired pneumonia.Clin Microbiol Infect,2016,22(1):94.e1-8.
  • 4Chawla K,Vishwanath S,Gupta A.Stenotrophomonas maltophilia in Lower Respiratory Tract Infections.J Clin Diagn Res,2014,8(12):DC20-22.
  • 5PerellóR,Escoda O,Camón S,et al.Changes in the etiology,incidence and prognosis of acute lower respiratory track infections in humanimmunodeficiency virus patients[J].Enferm Infecc Microbiol Clin,2015,33(4):243-247.
  • 6Greenbaum AH,Chen J,Reed C,et al.Hospitalizations for severe lower respiratory tract infections[J].Pediatrics,2014,134(3):546-554.
  • 7Volling C,Hassan K,Mazzulli T,et al.Respiratory syncytial virus infection-associated hospitalization in adults:a retrospective cohort study[J].BMC Infect Dis,2014,14:665.
  • 8吴金.ICU鲍氏不动杆菌医院感染临床研究[J].中华医院感染学杂志,2010,20(13):1931-1933. 被引量:20
  • 9李梅玲,程齐俭,瞿洪平.重症肺炎的抗炎辅助治疗进展[J].中华结核和呼吸杂志,2011,34(2):128-130. 被引量:25
  • 10李性天,耿立坚,周密妹.医院革兰阴性菌感染的防治策略[J].中国药业,2011,20(7):1-3. 被引量:3

引证文献8

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部